Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Generating Evidence Study for Systemic Lupus Erythematosus Using Different Types of Methodologies

NCT06698900 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06698900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06698900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Generating Evidence Study for Systemic Lupus Erythematosus Using Different Types of Methodologies
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 29, 2024
Completion date
December 20, 2024
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus